Kanbi  Pharma  Teknoloji  Limite
1337918-83-8 ZaveGepant

1337918-83-8 ZaveGepant

CAS: 1337918-83-8
MF: C36H46N8O3
MW: 638.8
Einecs:
Nimewo MDL: MFCD27938555

Voye rechèch
Dekri teren

Pwopriyete

Aparans blan nan koupe-blan solid
Pwen bouyi: 933.7 ± 65. 0 degre
Dansite 1.285 ± 0. 06 g/cm3
PKA11.68 ± 0. 70

 

Aplikasyon:

Zavegepant se yon vokasyon twazyèm-jenerasyon segondè ak segondè selectivite ti molekil molekil CGRP antagonist reseptè. Zavzpr É t (Zavegepant) se apwopriye pou tretman egi nan migrèn avèk oswa san Aura nan granmoun.

 

Sinonim:

Zavejepant

Vazegepant

1337918-83-8

Bms -742413

BHV -3500

Bms -742413-01

N-[(2r) -3- (7- methyl -1 H-Indazol -5- yl) -1- 11}} yl] -1- oxopropan -2- yl] -4- (2- oxo -1 h-quinolin {{18}

BHV3500

1- piperidinecarboxamide, 4- (1, 2- dihydro -2- oxo -3- quinolinyl) -n-((1r) -1- ({{{} }} yl) methyl) -2- (4- (1- methyl -4- Piperidinyl) -1- Piperazinyl) -2- oxoethyl)-

(R) -n-(3- (7- methyl -1 h-indazol -5- yl) -1- (4- (1- methylpiperidin {{{{{{{ 1}} yl) -1- oxopropan -2- yl) -4- (2- oxo -1, 2- dihydroquinolin {{}}} yl) piperidin {}}} {} yl) {} yl) {}} yl) {{

BHV 3500

ZevagePant

GTPL11513

BMS742413

742413

4- (1, 2- dihydro -2- oxo -3- quinolinyl) -n-((1r) {{ 8}} ((7- methyl -1 h-indazol -5- yl) methyl) -2- ( 4- (1- methyl -4- piperidinyl) -1- piperazinyl) -2- oxoethyl) -1- piperidinecarboxamidecarboxamide

evegepantum

Ex-A6698

 

Baj popilè: 1337918-83-8 ZaveGepant, Lachin 1337918-83-8 Zavgepant manifaktirè, Swèd

Inquiry
goTop

(0/10)

clearall